VICEBIO LIMITED
Research and experimental development on biotechnology
VICEBIO LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
2nd Floor 168 Shoreditch High Street London E1 6RA United Kingdom
Full company profile for VICEBIO LIMITED (11570257), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 14 Sept 2018. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2019–2023)
Cash in Bank
£1.81M
Net Assets
-£11.20M
Total Liabilities
£14.85M
Turnover
N/A
Employees
3
Debt Ratio
407%
Financial History
Revenue, profit, EBITDA and key financial figures
2023 31 Dec Year End | 2022 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (6)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 2 | Jul 2022 | Series B, Unknown/Other |
| Investor 1 | Sept 2024 | Series B |
| Investor 3 | Sept 2024 | Series B |
See all 6 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Cariad Chester | Director | American | United States | 29 Jul 2024 | Active |
| Giovanni Mariggi | Director | Italian | United Kingdom | 2 Nov 2018 | Active |
| Mark David Chin | Director | American | United States | 29 Jul 2024 | Active |
See all 10 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Sanofi Foreign Participations B.v.
Unknown
- Ownership Of Shares 75 To 100 Percent
- Voting Rights 75 To 100 Percent
- Right To Appoint And Remove Directors
Group Structure
Group Structure
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 7 Mar 2026 | Capital | Capital Name Of Class Of Shares | |
| 7 Mar 2026 | Capital | Capital Variation Of Rights Attached To Shares | |
| 28 Feb 2026 | Resolution | Resolutions | |
| 28 Feb 2026 | Incorporation | Memorandum Articles | |
| 7 Feb 2026 | Capital | Allotment of shares (GBP 7.2700) on 4 Dec 2025 |
Capital Name Of Class Of Shares
Capital Variation Of Rights Attached To Shares
Resolutions
Memorandum Articles
Allotment of shares (GBP 7.2700) on 4 Dec 2025
Recent Activity
Latest Activity
Capital Name Of Class Of Shares
3 months ago on 7 Mar 2026
Capital Variation Of Rights Attached To Shares
3 months ago on 7 Mar 2026
Resolutions
3 months ago on 28 Feb 2026
Memorandum Articles
3 months ago on 28 Feb 2026
Allotment of shares (GBP 7.2700) on 4 Dec 2025
4 months ago on 7 Feb 2026